Navigation Links
Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
Date:6/23/2008

IRVINE, Calif., June 23 /PRNewswire/ -- Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that Mr. Bruce Palsulich has joined the company as Chief Innovation & Strategy Officer, reporting directly to the CEO. In this role, he will oversee Relsys' future product development and direction, and drive corporate strategic initiatives.

Mr. Palsulich is one of Relsys' original employees, having been with the company since inception. He was formerly Vice President of Product Development at Relsys, departing in 2004 to pursue personal entrepreneurial initiatives. At the time, he was responsible for customer requirements, product direction and business development. Mr. Palsulich is also the original developer of the Argus Safety(TM) suite. He brings with him extensive knowledge and understanding of the pharmaceutical industry, particularly in risk management.

Mr. Dave Bajaj, President & CEO of Relsys, commented, "We welcome Bruce back to the Relsys organization. His return has been very well received by clients who have worked with him in the past. His broad, in-depth understanding of and exposure to global pharmacovigilance business practices will provide the backbone of our future product direction." Mr. Palsulich added, "Relsys has demonstrated unparalleled growth, rapidly gaining the largest user base of any drug safety system in the world. I look forward to working closely with this large client pool to continue to expand Relsys' risk management leadership."

About Relsys International

Relsys International provides the industry-leading Argus suite, a complete systems solution for drug safety, pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best selling drug safety and adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit http://www.relsys.net, or call +1 949-453-1715.


'/>"/>
SOURCE Relsys International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statement by Bruce Bodaken, Chairman & CEO, Blue Shield of California
2. White House awards Weill Cornells Bruce McCandliss highest honor for early career scientists
3. Dr. Lewis Drusin receives American College of Physicians James D. Bruce Memorial Award
4. Statement by Bruce Bodaken on Senate Health Committee Action
5. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
6. A product for the detection and characterization of brucellosis launched at University of Navarra
7. Richard Greco Joins Mediware Board
8. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
9. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
10. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
11. Nick Childs Joins Grey New York as Director of Content Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is ... product of her research center at Bio-Logic Aqua Research® Water Life Science®, has ... greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will ...
(Date:7/21/2017)... ... July 21, 2017 , ... The most common ... improved quality of life five years after injury, according to research presented today ... Toronto, Ontario, Canada. The study followed patients for five years following surgery. , ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Houston, is pleased to announce their expansion to the Midwest with the establishment ... Alysse Hollis and Ronald Bell, and of counsels, John Peck and Robert Bruns, ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... July 10, 2017  US medical equipment and supply ... according to Medical Equipment & Supplies: United ... Focus Reports. Continued increases in demand for medical services ... the population and supported by gains in disposable personal ... supplies. New product introductions will also drive sales as ...
(Date:7/6/2017)... ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is ... nutrition support. To celebrate its anniversary, ThriveRx recently launched a ... new look with improved organization to create the best user experience for ... ... "We,ve made several great strides ...
(Date:7/1/2017)... 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available ... call. The live audio webcast can be accessed ... It will be archived for replay following the conference call. ...
Breaking Medicine Technology: